Farxiga is a sodium-glucose cotransporter 2 (SGLT2) inhibitor. Here’s how it treats heart failure.

Jun 4, 2025 · Farxiga, also known by its generic name dapagliflozin, is a medication initially developed to treat type 2 diabetes. However, it is now a breakthrough treatment for heart failure. Approved by …

For adults with heart failure, when the heart cannot pump enough blood to the rest of the body, FARXIGA is a prescription medicine approved to reduce the risk of cardiovascular death, …

Farxiga is a sodium-glucose cotransporter 2 (SGLT2) inhibitor. Farxiga (dapagliflozin) is used for adults with heart failure with reduced ejection fraction. It is specifically for those with Class II through IV …

Why have you been prescribed FARXIGA? FARXIGA is a prescription drug used to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with heart …

Nov 17, 2025 · Farxiga (dapagliflozin) is a Type 2 diabetes treatment that can also treat heart failure in people with or without diabetes. It belongs to a class of medications called sodium-glucose …

Apr 19, 2024 · Farxiga is an oral prescription medicine containing the active ingredient dapagliflozin. It can be used to treat various conditions, including heart failure and Type 2 diabetes. Consult your …

The wholesale acquisition cost of 30-day supply of Farxiga is $565.30. 6 CONCLUSION ― Addition of the sodium-glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin (Farxiga) to standard heart failure …

Jun 17, 2025 · Heart failure medication can reduce symptoms and improve energy levels. People with heart failure need more than one medication to treat symptoms. Work with your health care team to …

Apr 1, 2022 · The 2022 heart failure guideline provides recommendations based on contemporary evidence for the treatment of these patients. The recommendations present an evidence-based …